Rheumatoid Arthritis Clinical Trials in Chicago

Showing 3361-3380 of 3,890 trials

CHARITE™ vs. ALIF 5-Year Follow-up

NCT00215332

To assess the clinical and radiographic outcomes through 5-years following treatment with CHARITÉ™ Artificial Disc vs. the BAK Cage for treatment of degenerative disc disease at one level (L4-S1).

Degenerative Disc Disease

DePuy Spine367 participantsStarted Mar 2005

Los Angeles, California, United States • Golden, Colorado, United States • Chicago, Illinois, United States +7 more locations

COMPLETEDPhase 22.2 miles

Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome

NCT00879606

This is a prospective, randomized (1:1), double-blind, multi-center, Phase II clinical study to test the safety and efficacy of a recombinant chimeric anti-tissue factor antibody (ALT-836) versus placebo in patients with sepsis and acute lung injury/acute respiratory distress syndrome (ALI/ARDS). This study was divided into two parts and the first part of the study has been completed. In the first part of the study, sixty patients were randomized at a 1:1 ratio to receive one dose of the study drug or placebo. In the second part of the study, ninety patients will be randomized at a 1:1 ratio to receive a multi-dose treatment regimen of single doses every 72 hours up to a maximum of 4 doses of the study drug or placebo, provided there are no safety concerns.

SepsisAcute Lung InjuryAcute Respiratory Distress Syndrome

Altor BioScience150 participantsStarted Apr 2009

Los Angeles, California, United States • Sacramento, California, United States • Stanford, California, United States +17 more locations

CHARITE™ vs. ALIF 5-Year Follow-up

Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome

Rheumatoid Arthritis Trials in Other Cities

Investigating Optical and Neural Causes of Vision Loss

Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication

Autologous CD34+ Stem Cell Injection for Severe Intermittent Claudication (Leg Pain)

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD

Development and Evaluation of a Hormone Replacement Therapy Decision-Aid

A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study

A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Phase IIIB Subcutaneous Abatacept Monotherapy Study

Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration

Grass Observational Study

Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma

A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Smoking Cessation for Young Adults Who Binge Drink - 1

Treatment of Subarachnoid Hemorrhage With Human Albumin

Other Conditions in Chicago